Allison Hulme

About Allison Hulme

Allison Hulme is a director at Ventyx Biosciences.

Form D filings name Allison Hulme as a chief executive officer & director at Aeovian Pharmaceuticals.

Allison Hulme reports to the SEC as a director or officer of 2 public companies, including Sophiris Bio (SPHS).

Allison Hulme first appears on SEC filings in 2013.

Experience

This experience comes from SEC filings. The years are when the filings name Allison Hulme in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Allison Hulme works with at each company, as listed on that company's latest Form D.

Sources

1. SECAeovian Pharmaceuticals, Inc. Form D, filed Dec 22, 2025
2. SECForms 3, 4 and 5 filed by Allison Hulme (SEC filer 1573886)